- Home
- LNTH vs EXLS Comparison
LNTH vs EXLS Comparison
Compare LNTH & EXLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LNTH | EXLS |
|---|---|---|
| Founded | 1956 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 5.1B |
| IPO Year | 2014 | 2004 |
Fundamental Metrics
Financial Performance| Metric | LNTH | EXLS |
|---|---|---|
| Price | $80.33 | $30.61 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 5 |
| Target Price | ★ $83.20 | $46.80 |
| AVG Volume (30 Days) | 1.0M | ★ 2.1M |
| Earning Date | 05-06-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 27.27 |
| EPS | ★ 3.41 | 1.54 |
| Revenue | $343,374,000.00 | ★ $2,087,679,000.00 |
| Revenue This Year | N/A | $12.85 |
| Revenue Next Year | $13.47 | $10.65 |
| P/E Ratio | $23.56 | ★ $19.87 |
| Revenue Growth | 3.62 | ★ 13.56 |
| 52 Week Low | $47.27 | $26.94 |
| 52 Week High | $108.86 | $48.79 |
Technical Indicators
Market Signals| Indicator | LNTH | EXLS |
|---|---|---|
| Relative Strength Index (RSI) | 61.41 | 42.11 |
| Support Level | $77.38 | $28.62 |
| Resistance Level | $83.70 | $32.98 |
| Average True Range (ATR) | 3.45 | 0.97 |
| MACD | -0.06 | 0.24 |
| Stochastic Oscillator | 67.23 | 35.64 |
Price Performance
Historical ComparisonAbout LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About EXLS ExlService Holdings Inc.
ExlService Holdings Inc. is a data analytics and digital operations company that provides data and AI-led solutions and technology-enabled services to clients across industries. The company has four reportable segments. The Insurance segment provides services such as claims management, underwriting support, and analytics solutions. The Healthcare and Life Sciences segment offers data-driven solutions and services to healthcare payers, providers, and life sciences organizations. The Banking, Capital Markets and Diversified Industries segment delivers solutions across financial services and other industries. The International Growth Markets segment focuses on providing data, AI, and digital operations services to clients outside North America.